CM-dextran-polyalcohol-camptothecin conjugate: DE-310 with a novel carrier system and its preclinical data.
Inoue
Kazuhiro
K
New Product Res. Lab. III, Daiichi Pharmaceutical Co., Ltd., 16-13, Kita-kasai 1, Edogawa-ku, Tokyo 134-8630, Japan.
Kumazawa
Eiji
E
Kuga
Hiroshi
H
Susaki
Hiroshi
H
Masubuchi
Noriko
N
Kajimura
Tetsuyo
T
D000438:Alcohols / Q000737:chemistry*; D000818:Animals; D000972:Antineoplastic Agents, Phytogenic / Q000737:chemistry* / Q000493:pharmacokinetics / Q000627:therapeutic use; D019540:Area Under Curve; D002166:Camptothecin / Q000737:chemistry* / Q000493:pharmacokinetics / Q000627:therapeutic use; D003911:Dextrans / Q000737:chemistry*; D004285:Dogs; D015195:Drug Design; D007275:Injections, Intravenous; D051379:Mice; D011108:Polymers / Q000737:chemistry*; D014018:Tissue Distribution
D000438:Alcohols; D000972:Antineoplastic Agents, Phytogenic; D003911:Dextrans; D011108:Polymers; C014392:carboxymethyl dextran; D002166:Camptothecin